Minimize Uncertainty – Make Informed Decisions – Succeed

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Boehringer Ingelheim & Sitryx Therapeutics autoimmune deal

February 27, 2026clinical trials,market access,immunology,biopharma,autoimmune,Lucid Diligence Brief,diligence,licensing deals,UK biotech,oral small molecules,immunometabolismpharma BD

Lucid Diligence Brief: Boehringer Ingelheim & Sitryx Therapeutics…

by Timos Papagatsias

Rare Disease news

Rare Disease Video Recap—February 26, 2026

February 26, 2026Affinia Therapeutics,Acetylleucine,ucb,Penn Medicine,BioPharma and Tech News,BAG3-Associated Dilated Cardiomyopathy,gastric cancer,CACNA1A-Related Disorders,Rare Disease News,Carbamoyl Phosphate Synthetase 1 Deficiency,Kygevvi,Thymidine kinase 2 deficiency,IntraBio,Erythropoietic protoporphyria,HanchorBio,Disc Medicine,Bitopertin,arginase-1 deficiencyImmedica,Pegzilarginase

This biweekly Rare Disease Video Recap covers key developments across the…

by LucidQuest

Cardiovascular

Cardiovascular Video Recap—February 26, 2026

February 26, 2026TransMedics Group,OCS Heart,HeartFlow,Mount Sinai,BioPharma and Tech News,Serbian SCAD Registry,Medtronic,Symplicity Spyral,pulmonary embolism,Resistant Hypertension,AccurKardia,Acute Myocardial Infarction,Cardiovascular News,aortic stenosis,coronary artery disease,Tetralogy of Fallot,Transcatheter aortic valve implantation,Spontaneous coronary artery dissection,AK-AVSGAMEFILM Registry,Pulmonary Embolism Response Team

This biweekly Cardiovascular Video Recap covers highlights regulatory…

by LucidQuest

Cardiovascular

Cardiovascular Today—Februrary 26, 2026

February 26, 2026BioPharma and Tech News,HEART FAILURECardiovascular Disease,hypertension,Renal Denervation,Medtronic,Cardiovascular News,Artificial intelligence in cardiology,Transcatheter aortic valve implantation,Percutaneous coronary intervention,Spontaneous coronary artery dissection,Women’s heart health

This weekly update in Cardiovascular & Stroke covers clinical progress,…

by LucidQuest

Rare Disease news

Rare Diseases Today—February 26, 2026

February 26, 2026Children’s Hospital of Philadelphia,Ministry of Food and Drug Safety South Korea,FDA,CAC,BioPharma and Tech News,Rare Disease News,Erythromelalgia,IntraBio,Affinia Therapeutics,Acetylleucine,Penn Medicine,BAG3-Associated Dilated Cardiomyopathy,National Organization for Rare Disorders,Rare Disease Day,Shanghai Jiao Tong UniversityDeepRare,AlzeCure Pharma

This week's Rare Disease update summarizes regulatory actions (orphan…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—February 26, 2026

February 26, 2026Tumor-infiltrating lymphocyte therapy,BCMA CAR T,Vertex Pharmaceuticals,Iovance Biotherapeutics,CRISPR Therapeutics,cell therapy manufacturing,Lifileucel,Sickle Cell Disease,REGENXBIO,Undifferentiated Pleomorphic Sarcoma,Hemophilia A,Sarepta Therapeutics,Dedifferentiated Liposarcoma,Biomarin,Kite Pharma,Elevidys,Casgevy,BioPharma and Tech News,Genetix Biotherapeutics,ROCTAVIAN,Lyfgenia,Ultragenyx,DTX401,Johnson & Johnson,Pariglasgene Brecaparvovec,Gilead Sciences,Glycogen Storage Disease Type Ia,Cell and Gene Therapy News,iRegene,Chugai Pharmaceutical,Arcellx,REQORSA,Anito-celGenprex,Anitocabtagene Autoleucel

This week's Cell and Gene therapy update highlights regulatory momentum,…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Turbine $25m Series B for virtual biology

February 26, 2026Oncology,market access,immunology,biopharma,Lucid Diligence Brief,venture funding,AI drug discovery,virtual biology,translational medicine,single-cell,drug combinations,platform diligencebenchmarking

Lucid Diligence Brief: Turbine $25m Series B for virtual biology Professional…

by Timos Papagatsias

Immunology

Immunology Video Recap—February 25, 2026

February 25, 2026remibrutinib,chronic spontaneous urticaria,novartis,Soficitinib,roche,Entyvio,takeda,Autoimmune pulmonary alveolar proteinosis,BioPharma and Tech News,primary membranous nephropathy,Eli Lilly,obinutuzumab,Ulcerative Colitis,Chronic Inducible Urticaria,TREMFYA,MOLBREEVI,Crohns Disease,Gazyva,Johnson & Johnson,STADA,Savara,Bio-Thera,Immunology News,Gotenfia,InnoCare Pharmamirikizumab,pediatric ulcerative colitis

This biweekly Immunology video recap highlights key developments across…

by LucidQuest

Neuroscience

Neuroscience Today—February 25, 2026

February 25, 2026Tirabrutinib,Apertura Gene Therapy,multiple sclerosis,FRRS1L Gene Therapy,Alzheimer's Disease,Deciphera Pharmaceuticals,merck,Central Nervous System Lymphoma,roche,Lario Therapeutics,Duchenne Muscular Dystrophy,Post-Traumatic Stress Disorder,schizophrenia,Olanzapine,BioPharma and Tech News,Enspryng,Parkinson's Disease,Artificial Intelligence Drug Discovery,Johnson & Johnson,Down Syndrome,Mayo Clinic,AC Immune,Daiichi Sankyo,SylamoreBio,Neuroscience News,Central Nervous System Drug DeliveryTeva Pharmaceuticals,Ionis Pharmaceuticals

This week's Neuroscience update highlights key developments, including…

by LucidQuest

Immunology

Immunology Today—February 25, 2026

February 25, 2026pediatric ulcerative colitis,MOLBREEVI,remibrutinib,Teva,Entyvio,novartis,Autoimmune pulmonary alveolar proteinosis,sanofi,Taltz,takeda,TOGETHER-PsO Trial,BioPharma and Tech News,Alembic Therapeutics,Zepbound,PIVYA,Eli Lilly,Uncomplicated Urinary Tract Infection,Ulcerative Colitis,Chronic Inducible Urticaria,TREMFYA,Alphyn Biologics,Crohns Disease,Zabalafin Hydrogel,Johnson & Johnson,Molluscum Contagiosum,Savara,Stoked Bio,Immunology News,Enterololinfood allergy,Duvakitug

This week's Immunology update summarizes covering clinical-trial readouts and…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Astellas collaboration with Vir Biotechnology

February 25, 2026Oncology,clinical trials,market access,Regulatory,prostate cancer,biopharma,immuno-oncology,Lucid Diligence Brief,diligence,royalties,T-cell engagersM&A and partnering

Lucid Diligence Brief: Astellas collaboration with Vir Biotechnology…

by Timos Papagatsias

Endocrinology

Endocrinology Video Recap—February 24, 2026

February 24, 2026Insulet,Omnipod 5,BioPharma and Tech News,Karolinska Institutet,Tirzepatide,circMTRNR2,type 2 diabetes,Diabetic Foot Ulcers,NICE,Avaí Bio,GLP-1 Receptor Agonists,Cell-Based Therapy,Endocrinology News,SGLT-2 Inhibitors,Continuous Glucose Monitoring,Implantable Insulin Pump,Automated insulin delivery,PRAESIIDIUM,Menopausal Hormone Therapy,Horizon Europe,Portal Diabetes,Prediabetes Risk Prediction,Portal Pump,LifeScanOneTouch Vita,i-SENS

Biweekly Endocrinology video recap covering key developments across care and…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.